Jason Davis's most recent trade in FibroBiologics Inc was a trade of 61,607 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| FibroBiologics Inc | Jason Davis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2026 | 61,607 | 61,607 | - | - | Stock Option (Right to Buy) | |
| FibroBiologics Inc | Jason Davis | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.41 per share. | 02 Mar 2026 | 70,000 | 70,000 | - | 0.4 | 28,973 | Common Stock |
| FibroBiologics Inc | Jason Davis | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 450,000 | 450,000 | - | - | Stock Option (Right to Buy) |